Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Trastuzumab emtansine delays and overcomes resistance to the third-generation EGFR-TKI osimertinib in NSCLC EGFR mutated cell linesLa Monica, Silvia ; Cretella, Daniele ; Bonelli, Mara ; Fumarola, Claudia ; Cavazzoni, Andrea ; Digiacomo, Graziana ; Flammini, Lisa ; Barocelli, Elisabetta ; Minari, Roberta ; Naldi, Nadia ; Petronini, Pier Giorgio ; Tiseo, Marcello ; Alfieri, RobertaJournal of experimental & clinical cancer research, 2017-12, Vol.36 (1), Article 174 [Periódico revisado por pares]London: BioMed CentralTexto completo disponível |
|
2 |
Material Type: Artigo
|
Immune Checkpoint Immunotherapy for Non-Small Cell Lung CancerSuresh, Karthik ; Naidoo, Jarushka ; Lin, Cheng Ting ; Danoff, SonyeChest, 2018-12, Vol.154 (6), p.1416-1423 [Periódico revisado por pares]Elsevier IncTexto completo disponível |
|
3 |
Material Type: Artigo
|
Immune Cell Composition in Human Non-small Cell Lung CancerStankovic, Branislava ; Bjørhovde, Heidi Anine Korsmo ; Skarshaug, Renate ; Aamodt, Henrik ; Frafjord, Astri ; Müller, Elisabeth ; Hammarström, Clara ; Beraki, Kahsai ; Bækkevold, Espen S. ; Woldbæk, Per Reidar ; Helland, Åslaug ; Brustugun, Odd Terje ; Øynebråten, Inger ; Corthay, AlexandreFrontiers in immunology, 2018, Vol.9, p.3101-3101 [Periódico revisado por pares]Texto completo disponível |
|
4 |
Material Type: Artigo
|
Corrigendum: ITGAL expression in non-small-cell lung cancer tissue and its association with immune infiltratesZhang, Ruihao ; Zhu, Guangsheng ; Li, Zaishan ; Meng, Zhenzhen ; Huang, Hua ; Ding, Chen ; Wang, Yanan ; Chen, Chen ; Li, Yongwen ; Liu, Hongyu ; Chen, JunFrontiers in immunology, 2024, Vol.15, p.1415814-1415814 [Periódico revisado por pares]Switzerland: Frontiers Media S.ATexto completo disponível |
|
5 |
Material Type: Artigo
|
Cost-effectiveness of sotorasib as a second-line treatment for non-small cell lung cancer with KRASG12C mutation in China and the United StatesZhu, Ya-Ning ; Tang, Meng ; Sun, Ke-Xin ; Gao, Bei ; Shi, Xian-Peng ; Zhang, PengFrontiers in pharmacology, 2024-06, Vol.15, p.1348688 [Periódico revisado por pares]Frontiers Media S.ATexto completo disponível |
|
6 |
Material Type: Artigo
|
YTHDF2 Inhibits the Migration and Invasion of Lung Adenocarcinoma by Negatively Regulating the FAM83D-TGFβ1-SMAD2/3 PathwayZhao, Teng ; Wang, Mingchao ; Zhao, Xin ; Weng, Shuang ; Qian, Kun ; Shi, Kejian ; Gu, Yanfei ; Ying, Wantao ; Qian, Xiaohong ; Zhang, YiFrontiers in oncology, 2022-02, Vol.12, p.763341-763341 [Periódico revisado por pares]Switzerland: Frontiers Media S.ATexto completo disponível |
|
7 |
Material Type: Artigo
|
lncRNA FOXD2-AS1 confers cisplatin resistance of non-small-cell lung cancer via regulation of miR185-5p–SIX1 axisGe, Peng ; Cao, Lei ; Yao, Yue-Juan ; Jing, Rui-Jun ; Wang, Wei ; Li, Han-JieOncoTargets and therapy, 2019-07, Vol.12, p.6105-6117 [Periódico revisado por pares]DoveTexto completo disponível |
|
8 |
Material Type: Artigo
|
A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-1 in Metastatic Solid Malignancies Including MET Exon 14 Mutated Lung CancerPruis, Melinda A ; Krebs, Matthew G ; Plummer, Ruth ; De Vos, Filip ; Angevin, Eric ; Prenen, Hans ; Forster, Martin D ; Clack, Glen ; Van der Aa, Annegret ; Tjwa, Marc ; Jansen, Ellen ; Perera, Timothy ; Lolkema, Martijn P2023-12Texto completo disponível |
|
9 |
Material Type: Artigo
|
Assessing the robustness of radiomics/deep learning approach in the identification of efficacy of anti–PD-1 treatment in advanced or metastatic non-small cell lung carcinoma patientsRen, Qianqian ; Xiong, Fu ; Zhu, Peng ; Chang, Xiaona ; Wang, Guobin ; He, Nan ; Jin, QiannaFrontiers in oncology, 2022-08, Vol.12, p.952749-952749 [Periódico revisado por pares]Frontiers Media S.ATexto completo disponível |
|
10 |
Material Type: Artigo
|
Immunotherapy and brain metastasis in lung cancer: connecting bench side science to the clinicRios-Hoyo, Alejandro ; Arriola Aperribay, EdurneFrontiers 2023Texto completo disponível |